drugset / Trial / NCT02276274

Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects

NCT02276274 ↗

Phase 3 Completed 12 enrolled Takeda
RandomizedCrossoverOpen-labelBasic science

Summary

This is a randomized, open-label, crossover study to determine the effect of food when a combination tablet of SYR-322 and metformin hydrochloride ( hereinafter referred to as SYR-322-MET tablet) is orally administered under fasting conditions in the morning or after breakfast in Japanese healthy adult male subjects.

Timeline

Start
2014-06
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule — Oral
Subject SYR-322 Unknown — Oral

Indications

No indication recorded.